What's New - HKAPI

22 May 23

HKAPI Welcomes Four New Members

We are excited to share that the HKAPI has welcomed four new members to our organization over the past year. These companies are bringing new and diverse expertise to our organization and we are thrilled to have them on board.

19 May 23

Pfizer Renewed as HKAPI Full Member

HKAPI is pleased to announce that Pfizer has renewed as full member of the Association.

17 May 23

HKAPI joined the Panel at 3rd ASGH Project Pitching Sessions

We are delighted to announce that our Senior Executive Director, Ms. Sabrina Chan, was invited by the Hong Kong Trade Development Council (HKTDC) to participate in the 3rd Asia Summit on Global Health (ASGH) as one of the panelists for the Project Pitching Sessions.

05 Apr 23

Appointment of New Board Members

HKAPI has announced the election of two new members to its Board of Directors. Mr Neo Lam, from Baxter, and Mr Jonathan Chin, from Boehringer Ingelheim, have been elected to join the Board and will serve until the end of this term (2024).

22 Mar 23

Successful AGM of the Hong Kong Association of the Pharmaceutical Industry

We are delighted to announce that the Annual General Meeting (AGM) of the Hong Kong Association of the Pharmaceutical Industry was held successfully on 22nd March 2023.

17 Mar 23

HKAPI Representatives visited Nan Sha, Guangdong

Representatives from the HKAPI GBA task force recently participated in a two-day trip to Nan Sha, Guangdong, on March 16-17.

11 Mar 23

Ms Sabrina Chan shared her insights on PGx trend in a recent webinar

Ms Sabrina Chan, Senior Executive Director of HKAPI, was invited to be one of the speakers at a recent webinar about pharmacogenetics on 11 March.

01 Mar 23

Hong Kong Competition Law Update – Recent enforcement trends and impact on pharmaceutical industry

Over 30 members attended the seminar on-site, and 50 joined virtually.

16 Feb 23

HKAPI x HKSTP – How AI is Transforming Drug Discovery and Clinical Trial Design

The "Symposium - How AI is Transforming Drug Discovery and Clinical Trial Design" was a huge success, with drug developers and investors in attendance to learn about the latest AI technologies in drug discovery and clinical development.

13 Feb 23

Briefing session for Regulatory Intelligence Survey

The Hong Kong Association of Pharmaceutical Industry organized a successful briefing session for its Regulatory Intelligence Survey, attracting over 50 members to join the event.

HKAPI Welcomes Four New Members

Pfizer Renewed as HKAPI Full Member

HKAPI joined the Panel at 3rd ASGH Project Pitching Sessions

Appointment of New Board Members

Successful AGM of the Hong Kong Association of the Pharmaceutical Industry

HKAPI Representatives visited Nan Sha, Guangdong

Ms Sabrina Chan shared her insights on PGx trend in a recent webinar

Hong Kong Competition Law Update – Recent enforcement trends and impact on pharmaceutical industry

HKAPI x HKSTP – How AI is Transforming Drug Discovery and Clinical Trial Design

Briefing session for Regulatory Intelligence Survey

© The Hong Kong Association of the Pharmaceutical Industry | 香港科研製藥聯會

All Right Reserved

Disclaimer

Privacy

Terms of Use